Skip to main content

Table 3 The unit cost associated with TAVI and SAVR in current Iran’s clinical pathway for AS treatment

From: Transcatheter aortic valve implantation against conventional aortic valve replacement surgery in high-risk patients with aortic stenosis; a cost-effectiveness analysis

cost Item*

Mean cost*

Standard Deviation

Distribution of Interest

Source

SAVR costs of the procedure

12,811,000 (51)

–-

 

[27]

TAVI costs of the procedure

20,052,000 (80)

–-

 

[27]

TAVI costs of hospitalization

43,200,000 (173)

4,032,654

Gamma

[28]

SAVR costs of hospitalization

75,750,000 (303)

4,326,731

Gamma

[28]

Stent costs TAVI

450,000,000 (1,800)

–-

 

[27]

Valve Costs

800,000,000 (3,200)

–-

 

[27]

Permanent Peace Maker Implantation Procedure or Implantable cardioverter defibrillators (ICDs)

Cost

9,183,500 (37)

–-

 

[27]

Cost of Angioplasty

7,398,300 (29)

–-

 

[27]

Reoperation TAVI

10,026,000 (40)

1,430,401

Gamma

[27]

Reoperation SAVR

6,405,500 (26)

2,720,528

Gamma

[27]

CABG

22,280,000 (89)

–-

 

[27]

  1. *All costs are Iranian Rial (US$ equivalent)